Symphera provides an all-in-one surgical system that makes minimally-invasive procedures more efficient.
Symphera has raised $2.8M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
Symphera's investors include HTGF (High-Tech Gruenderfonds), Bayern Kapital, Carma Fund, IRCAD Institut de Recherche contre les Cancers de l'Appareil Digestif, UnternehmerTUM.
Symphera is headquartered in Munchen, Germany.
Symphera provides an all-in-one surgical system that makes minimally-invasive procedures more efficient.
Symphera is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Symphera — Funding & Investors." VCBacked, September 16, 2024, https://www.vcbacked.co/company/symphera. Accessed September 5, 2026.
VCBacked. (2024). Symphera — Funding & Investors. Retrieved September 5, 2026, from https://www.vcbacked.co/company/symphera
{{cite web |title=Symphera — Funding & Investors |url=https://www.vcbacked.co/company/symphera |website=VCBacked |access-date=September 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated